Combination of Brentuximab Vedotin and Pembrolizumab as Salvage Treatment Before Autologous Stem Cell Transplantation and Maintenance in Patients with Relapsed/Refractory Hodgkin Lymphoma.

Auteurs

Massa H, Massaro F, Maerevoet M

  • Date de publication

    January 2025

  • Type

    Article

  • Review

    Biomedicines

  • Researcher's name

    MASSA HANNE

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Interne

  • PMID

    40002670

  • DOI

    10.3390/biomedicines13020252